---
title: Critical survival periods in prostate cancer in Sweden explored by conditional
  survival analysis
date: '2024-03-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38545829/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240328180704&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The data indicate that M1 metastases kill more patients
  in the first 2.5 years than between years 2.5 and 5 after diagnosis; T4 deaths are
  equal in the two periods, and in T3 mortality in the first 2.5-year period is lower
  than between years 2.5 and 5 after diagnosis. Conditional survival could be applied
  to explore critical survival periods even past 5 years after diagnoses and to monitor
  success in novel diagnostic and treatment practices. Improvement of survival in
  ...'
disable_comments: true
---
CONCLUSIONS: The data indicate that M1 metastases kill more patients in the first 2.5 years than between years 2.5 and 5 after diagnosis; T4 deaths are equal in the two periods, and in T3 mortality in the first 2.5-year period is lower than between years 2.5 and 5 after diagnosis. Conditional survival could be applied to explore critical survival periods even past 5 years after diagnoses and to monitor success in novel diagnostic and treatment practices. Improvement of survival in ...